UVA advances precision medicine to defeat breast cancer with Komen grant

FHS
July 20, 2024
1:49 am

Through precision medicine, the University of Virginia is working toward a world in which no more pink ribbons are necessary. To that end, Susan G. Komen announced support this summer for the UVA School of Engineering and Applied Science’s efforts to apply systems biology research to defeat breast cancer.

Georgiamune and Verily Partner to Advance Novel Cancer Treatment

What You Should Know: – Georgiamune, a privately held, clinical stage biotechnology company, and Verily, an Alphabet precision health technology company forms a strategic partnership

October 27, 2023

Syndax’s stock sinks by 25% despite AML trial meeting primary endpoint – Pharmaceutical Technology

The AUGMENT-101 trial evaluated the safety and efficacy of revumenib in adults with relapsed or refractory mutant NPM1 AML. Credit: SeventyFour via Shutterstock. Syndax Pharmaceuticals

November 13, 2024

Make the Diagnosis: Eeesh….When Something Goes “Pop” While You’re Weightlifting

Presentation A 48-year-old man presented to the doctor with complaints of elbow pain that developed on his right arm after weightlifting earlier that day. He

January 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.